ABVC BioPharma, Inc. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ABVC BioPharma, Inc. stock issued during period, value, other for the quarter ending 2026-03-31 was $63.49K.
- ABVC BioPharma, Inc. stock issued during period, value, other for the quarter ending 2024-12-31 was -$133.73K.
- ABVC BioPharma, Inc. stock issued during period, value, other for the quarter ending 2024-09-30 was $33.73K.
- ABVC BioPharma, Inc. stock issued during period, value, other for the quarter ending 2024-06-30 was $131.04K.
- ABVC BioPharma, Inc. stock issued during period, value, other for fiscal 2024 was $31.04K.
- ABVC BioPharma, Inc. stock issued during period, value, other for fiscal 2012 was $11.25K, a 90.18% decline from fiscal 2011.
- ABVC BioPharma, Inc. stock issued during period, value, other for fiscal 2011 was $114.50K.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2026-03-31 | $63.49K 10-Q · filed 2026-05-18 | |
| 2024-12-31 | -$133.73K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-03 | $31.04K 10-K · filed 2026-03-03 |
| 2024-09-30 | $33.73K 10-Q/A · filed 2026-03-03 | |
| 2024-06-30 | $131.04K 10-Q · filed 2025-08-13 | |
| 2021-09-30 | $6.02M 10-Q · filed 2021-11-15 | |
| 2012-09-30 | $11.25K 10-K · filed 2015-04-16 | |
| 2011-09-30 | $114.50K 10-K · filed 2015-04-15 |